AKT1 and psychiatric disorder: In addition, Akt/GSK3β signaling is associated with the treatment responses of therapeutic agents of mental illness (Beaulieu et al., 2009; Kim et al., 2009; Zhang et al., 2010; Kitagishi et al., 2012; Costemale-Lacoste et al., 2016).